India Glycols Limited · NSE:INDIAGLYCO
India Glycols — Q1 FY2023-24 Earnings Presentation
33 slides from India Glycols's earnings presentation, Aug 9, 2023
Slide 1: Exchange filing cover letter
9th August, 2023 The Manager (Listing) The Manager (Listing) BSE Limited National Stock Exchange of India Limited 1st Floor, New Trading Ring, Exchange Plaza, C-1, Block G, Rotunda Building, P.J. Towers, Bandra Kurla Complex, Dalal Street, Mumbai – 400 001 Bandra (East), Mumbai- 400 051 Scrip Code:
Slide 2: Investor Presentation Q1 FY 2023-24
India Glycols Limited Positive Impact Bio-based Ingredients & Performance Chemicals v v v Investor Presentation Q1 FY 2023-24 1
Slide 3: Safe Harbour Statement
Safe Harbour Statement This presentation and the following discussion may contain “forward looking statements” by India Glycols Limited (“IGL” or the company) that are not historical in nature. These forward-looking statements, which may include statements relating to future results of operations, f
Slide 4: Q1FY24 Performance
Q1FY24 Performance INDIA GLYCOLS LIMITED
Slide 5: Performance Overview
Performance Overview Q1FY24 vs Q1FY23 Gross Turnover EBITDA PAT 1,894 Cr 106 Cr 51 Cr +1.4 % + 54.0 % + 85.4% Net Turnover EBITDA Margin PAT Margin 689 Cr 15.2% 7.4% - 14.7% + 697 bps + 397 bps ⦁ Witnessed overall a strong quarter with improved profitability and margins ⦁ High international ethanol
Slide 6: Highlights – Q1FY24
Highlights – Q1FY24 Business Performance □ Overall, strong profit growth in Q1 over Q1-FY-23. o PBT with share of profits in JV, is up by 83.7% ( YoY basis), o PAT stood at Rs. 51 Cr in Q1, up by 85.4% (YoY basis) □ Excellent EBITDA performance compared to Q1 FY-23, This is led mainly by PS and BSPC
Slide 7: Highlights – Q1FY24 Other Highlights
Highlights – Q1FY24 Other Highlights □ Grain based ethanol capacities have helped mitigate impact of ethanol cost increases □ International ethanol prices stay high. Some signs of softening future ethanol prices – early to say whether trend will be sustained. □ Plan for further Grain Capacity expans
Slide 8: Business Segment Highlights
Business Segment Highlights Bio-based Specialities and Performance Potable Spirits (PS) Ennature Biopharma (EB) Chemicals (BSPC) □ Q1 Revenue at Rs. 401 Cr., down 26.8% □ Q1 Revenue at Rs. 235 Cr., up by 14.7% □ Q1 Revenue up at Rs. 53 Cr., down 3.3% □ EBIT Q1 at Rs. 41 Cr., up 73.1% □ EBIT for Q1 a
Slide 9: Financial Summary - Consolidated
Financial Summary - Consolidated Particulars (In INR Cr) Q1FY24 Q1FY23 Y-o-Y (%) Q4FY23 Q-o-Q (%) FY23 FY22 Y-o-Y (%) Revenue from operations (net of excise) 689 808 (14.7%) 619 11.2% 2,651 2,868 (7.6%) Other Income 6 6 (6.0%) 4 29.8% 24 22 10.9% Total Income 695 814 (14.7%) 624 11.4% 2,675 2,890 (7
Slide 10: Financial Summary - Standalone
Financial Summary - Standalone Particulars (In INR Cr) Q1FY24 Q1FY23 Y-o-Y (%) Q4FY23 Q-o-Q (%) FY23 FY22 Y-o-Y (%) Revenue from operations (net of excise) 688 808 (14.9%) 619 11.1% 2,650 2,863 (7.4%) Other Income 6 7 (21.8%) 4 36.8% 28 27 4.0% Total Income 694 815 (14.9%) 623 11.2% 2,678 2,890 (7.3
Slide 11: Segment Performance - Consolidated
Segment Performance - Consolidated (In INR Cr) Q1FY24 Q1FY23 % YoY Q4FY23 % QoQ FY23 FY22 % YoY Bio-based Specialities and Performance Chemicals (BSPC) Net Revenue 401 549 (26.8%) 389 3.1% 1,705 2,026 (15.9%) EBIT 41 24 73.1% 42 (2.3%) 125 121 3.3% % margin 10.3% 4.4% 596 bps 10.9% (57 bps) 7.3% 6.0
Slide 12: Segmental Revenue and EBIT Mix - Consolidated
Segmental Revenue and EBIT Mix - Consolidated Revenue Mix EBIT Mix 7% 8% 13% 40% 43% 23% 58% 25% 68% 34% 44% 37% Q1FY23 Q1FY24 Q1FY23 Q1FY24 5% 7% 16% 18% 24% 64% 45% 48% 29% 71% 36% 37% FY23 FY22 FY23 FY22 BSPC PS Ennature Biopharma BSPC PS Ennature Biopharma 11
Slide 13: Company Overview
Company Overview INDIA GLYCOLS LIMITED 12
Slide 14: IGL at a Glance
IGL at a Glance Go Green Diversified product portfolio Global Standards with inherent synergies Compliance with stringent global 1st in the world to use Innovative Green Technologies to manufacture Bio-based Specialties, Bio-Polymers, standards of plant operations, bio-based ethylene oxide & Potable
Slide 15: Key Milestones
Key Milestones New Grain based Formulatio Ethanol plant – Gorakhpur n Gorakhpur & Distillery & Sulphation Kashipur First EO Glycol E2 Thiocolchicosi Bio Polymers | Textile US JV Distille Purificat MEG 600 de Nicotine Green Solvents ENA Subsidiar Clariant ry ion TPD Expansion y 1988 1990 1994 1996 20
Slide 16: Portfolio Leading in Bio-based Ingredients and Performance Chemicals
Portfolio Leading in Bio-based Ingredients and Performance Chemicals Bio-based Specialities Segments And Performance Potable Spirits (PS) Ennature Biopharma Chemicals (BSPC) Revenue Mix Net revenue share 64% Net revenue share 28% Net revenue share 7% (Consol. FY23) □ Bio-based Glycols (MEG, DEG, TEG
Slide 17: JV with Clariant: Leaders in bio-based ethoxylates and derivatives
JV with Clariant: Leaders in in bio-based ethoxylates and derivatives Promoters Public 1 - Shareholding Combining production and distribution capacity, as 61.01% 1 38.99% 1 on 30th June 2021 the joint venture is establishing to become a leading supplier of renewable materials to the rapidly growing
Slide 18: Leveraging synergies to create value–integrated manufacturing
Leveraging synergies to create value–integrated manufacturing for bio-based products Portable Spirits (PS) Products Potable Spirit Industrial Gas ENA Power Alcohol O2, N2, Ar Brands Division Ind Gr. CO2 Grain O2 ASU EO-CO2 mix Business transferred to JV with Clariant Bio-based Specialities Green And
Slide 19: Manufacturing Capabilities
Manufacturing Capabilities Kashipur Gorakhpur Dehradun 300-acre state of art integrated manufacturing complex 56-acre state of art distillation & bottling complex 160,000 sqft state of art facility Fermentation – Molasses and Grain Based Grain based Ethanol High Purity Extraction Ethanol Distillatio
Slide 20: R&D: Creating value through New Product Development
R&D: Creating value through New Product Development; focus on Green Chemistry 1 Focus on NPD, designing products for the future in collaboration with our reputed customers 2 DSIR Recognized R&D at Dehradun and Kashipur 3 Exploiting available feed stocks of Bio-Alcohol, Smart Alcohol, Ethylene Oxide,
Slide 21: Business Segments
Business Segments INDIA GLYCOLS LIMITED 20
Slide 22: Bio-based Specialities and Performance Chemicals (BSPC)
Bio-based Specialities and Performance Chemicals (BSPC) First in the world to manufacture ethylene oxide and glycols from bio-based feedstocks e.g. Molasses, Grain Largest manufacturer of Bio-based glycols and Bio-based Ethylene Oxide made from renewable feedstock i.e. Molasses Products for a
Slide 23: Potable Spirits
Potable Spirits License for operations and sale of Country Liquor in the States of Uttar Pradesh and Uttarakhand. Also operates and sells Indian Made Foreign Liquor (“IMFL”) from its own unit and few tie-up units Company brands are available in the states of Uttarakhand, Uttar Pradesh, Delhi and
Slide 24: Ennature Biopharma
Ennature Biopharma Operates in the space of Nutraceuticals, Phytochemicals & health supplement ingredients. One of the leaders in Complex phytochemicals chemistry in India Global leader in Thiocolchicoside, a highly potent muscle relaxant API Advanced production capabilities, including organic
Slide 25: IGL - Catering to diverse end markets
IGL - Catering to diverse end markets • Glycols are used for the manufacture of polyester yarn, fibre, film and resin and as an automobile coolant • Bio-glycols cater to the beverage and food industry's packaging requirement of PET bottles and polyester film • Ethyl / Butyl glycol ethers and its ace
Slide 26: Growth Drivers
Growth Drivers 25
Slide 27: Growth Drivers
Growth Drivers High prospects of growth of industry sectors being serviced by IGL – Personal Care, Automotive, Packaging, Beverages, Oil & Gas, Home Care, Pharma, Nutraceuticals etc, Textiles – most expected to grow at near double digit or more Increasing consumer awareness and demand for sustai
Slide 28: Yearly financial Performance
Yearly financial Performance 27
Slide 29: 4-year Financial Trajectory - Consolidated
4-year Financial Trajectory - Consolidated In INR Net Revenue (Excl. EBITDA (Excl. Discontinued PAT (Excl. Discontinued Biz.) Cr Discontinued Biz.) Biz.) 330 319 2,744 2,890 288 283 277 2,675 2,332 141 109 75 FY2020 FY2021 FY2022 FY2023 FY2020 FY2021 FY2022 FY2023 FY2020 FY2021 FY2022 FY2023 Net Rev
Slide 30: 4-year Financial Trajectory - Consolidated
4-year Financial Trajectory - Consolidated EBITDA Margin (%) (Excl. PAT Margin (%) (Excl. Discontinued RoE (%) Discontinued Biz.) Biz.) 11.4% 12.1% 11.9% 10.5% 19.2% 9.6% 5.3% 11.1% 11.3% 4.7% 7.4% 2.7% FY2020 FY2021 FY2022 FY2023 FY2020 FY2021 FY2022 FY2023 FY2020 FY2021 FY2022 FY2023 EBITDA Margin
Slide 31: Sustainability, ESG and Certifications
Sustainability, ECG and Certifications
Slide 32: Sustainability, ESG
Sustainability, ESG Environment Stewardship • World’s first and largest producer of Bio-Based EO and its derivatives • Next Generation CarbonSmart products from emissions (fossil carbon) - collaboration with Transparent Accountable LanzaTech & consumer majors like Unilever and Lululemon • Environmen
Slide 33: Thank you
Thank you Ernst & Young LLP India Glycols Limited CIN: L24111UR1983PLC009097 Runjhun Jain Ankur Jain runjhun.jain1@in.ey.com Company Secretary & Compliance Officer Head office Rohit Anand rohit.anand4@in.ey.com 2B, Sector-126, Noida Tel: +91-120-6860000, 3090100, 3090200 Gautam Budh Nagar Fax: +91-1